Nicolet Bankshares Inc. Cuts Stock Holdings in CVS Health Co. (NYSE:CVS)

Nicolet Bankshares Inc. cut its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 26.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,589 shares of the pharmacy operator's stock after selling 4,183 shares during the period. Nicolet Bankshares Inc.'s holdings in CVS Health were worth $520,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Morse Asset Management Inc bought a new position in CVS Health during the third quarter valued at approximately $409,000. Wellington Management Group LLP grew its stake in shares of CVS Health by 6.2% in the 3rd quarter. Wellington Management Group LLP now owns 224,248 shares of the pharmacy operator's stock worth $14,101,000 after buying an additional 13,120 shares in the last quarter. Coldstream Capital Management Inc. grew its position in CVS Health by 27.8% in the third quarter. Coldstream Capital Management Inc. now owns 17,400 shares of the pharmacy operator's stock worth $1,084,000 after acquiring an additional 3,788 shares in the last quarter. Westside Investment Management Inc. lifted its stake in shares of CVS Health by 4.6% in the 3rd quarter. Westside Investment Management Inc. now owns 64,517 shares of the pharmacy operator's stock valued at $4,041,000 after purchasing an additional 2,856 shares during the last quarter. Finally, Sanctuary Advisors LLC raised its holdings in CVS Health by 42.0% during the 3rd quarter. Sanctuary Advisors LLC now owns 192,436 shares of the pharmacy operator's stock valued at $11,163,000 after buying an additional 56,890 shares during the period. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CVS. Argus set a $77.00 target price on shares of CVS Health in a report on Tuesday, February 18th. Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. StockNews.com upgraded CVS Health from a "sell" rating to a "hold" rating in a research note on Thursday, February 13th. Truist Financial lifted their price objective on shares of CVS Health from $76.00 to $82.00 and gave the company a "buy" rating in a report on Friday, April 11th. Finally, Leerink Partnrs raised CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $71.83.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney bought 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company's stock.

CVS Health Stock Performance

Shares of CVS Health stock traded down $1.00 during midday trading on Thursday, hitting $67.55. The company had a trading volume of 11,433,621 shares, compared to its average volume of 11,772,447. The company has a fifty day simple moving average of $65.96 and a 200 day simple moving average of $58.70. The stock has a market cap of $85.16 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 0.98 and a beta of 0.57. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.94%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.